Isbn: 9780896039193 - tumor targeting in cancer therapy (9 risultati)

- Rilegato
Da: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 98,14
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibile
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

- Rilegato
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.Romtrade Corp.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 131,85
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibile
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

- Rilegato
Da: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 131,85
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibile
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

- Rilegato
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 250,00
EUR 17,41 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In English.

Lingua: Inglese
Editore: Humana Press Inc., 2002
Serie: Libro 12 di 96 - Cancer Drug Discovery and Development
- Rilegato
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 255,34
EUR 9,50 spedizioneSpedito da Irlanda a U.S.A.Quantità: 15 disponibili
Condizione: New. Introduces the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. This title illuminates this technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy and radioimmunodetection. Editor(s): Page, Michel. Series: Cancer Drug Discovery and Development. Num Pages: 463 pages, 39 black & white illustrations, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 26. Weight in Grams: 1039. . 2002. Hardback. . . . .…

Lingua: Inglese
Editore: Humana Press, 2002
Serie: Libro 12 di 96 - Cancer Drug Discovery and Development
- Rilegato
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 227,74
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Gebunden. Condizione: New. Part I. A Review The Current Status of Tumor Targeting: A Review Tarunendu Ghose Clinical Applications of Targeted Therapeutics Tarunendu Ghose Part II. Targeting Tumors with Drug Antibody Conjugates Targeting the CD22 Receptor with RNA Damaging Agents .

Lingua: Inglese
Editore: Humana Press, 2002
Serie: Libro 12 di 96 - Cancer Drug Discovery and Development
- Rilegato
Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 314,97
EUR 17,48 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Hardcover. Condizione: Brand New. 400 pages. 10.25x7.00x1.25 inches. In Stock.

Lingua: Inglese
Editore: Humana Press Inc., 2002
Serie: Libro 12 di 96 - Cancer Drug Discovery and Development
- Rilegato
Da: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 325,45
EUR 9,23 spedizioneSpedito in U.S.A.Quantità: 15 disponibili
Condizione: New. Introduces the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. This title illuminates this technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy and radioimmunodetection. Editor(s): Page, Michel. Series: Cancer Drug Discovery and Development. Num Pages: 463 pages, 39 black & white illustrations, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 26. Weight in Grams: 1039. . 2002. Hardback. . . . . Books ship from the US and Ireland.…

Lingua: Inglese
Editore: Humana Press Apr 2002, 2002
Serie: Libro 12 di 96 - Cancer Drug Discovery and Development
- Rilegato
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 318,78
EUR 43,04 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Buch. Condizione: Neu. Neuware - After many years of vigorous effort, the use of antibodies to target tumors has become highly successful both clinically and commercially. In Tumor Targeting in Cancer Therapy, Dr. Michel Pagé and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. By concisely synthesizing the many technical details, the authors illuminate this innovative technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy, radioimmunodetection, therapy with cytotoxic antibodies, immunotoxins, enzyme prodrug immunotherapy, and immunotherapeutics with fusion proteins. There are also reviews of targeting tumors with radioimmunoconjugates, photodynamic therapy, and magnetic drugs, as well as discussions of the internalization of antibodies, bioconjugation and biodistribution, the use of cytotoxic drugs, and the pros and cons of targeting by antibody or ligand. Comprehensive and practical, Tumor Targeting in Cancer Therapy summarizes the essentials of tumor targeting as it is practiced today and provides all those engaged in experimental and clinical cancer research the critically established information needed to evaluate new technologies, investigate novel therapeutic agents, and apply them in relevant clinical practice.…